Skip to Main Content

Paper Details

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Cancer Medicine
21
2020
CAPOX, CAPOX-B, PD1, PD2, SMI, Sarcopenia, bevacizumab, capecitabine, mCRC, metastatic colorectal cancer, oxaliplatin, p3, patients
Author NameAffiliation
Petra H M PeetersJulius Center for Health Sciences and Primary Care, Utrecht University
  • 1 - 1

Datasets

Release 1.2